LAKE OSWEGO, Ore. & BERLIN--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of implantable cardiac devices and
pioneer of wireless remote monitoring technologies, today announced the
US market release of the Selectra left ventricular lead delivery system.
Selectra delivers a significant advancement in lead placement systems
for cardiac resynchronization therapy (CRT) devices.

“BIOTRONIK spent considerable time understanding electrophysiologists’
needs and examining the challenges they face with current lead delivery
systems: it is this intensive insight that has formed the basis for
engineering Selectra’s advanced design,” commented Jake Langer,
President of BIOTRONIK, Inc., USA. “In a challenging CRT case, there are
two concerns regarding lead delivery. First, you have to ensure that
you’ve achieved optimal lead placement; then you must be able to remove
the catheter without altering the position of the lead. The Selectra
system appears to be very promising in terms of balancing flexibility
and firmness, which will allow easy access to the coronary sinus.
Splitting the Selectra sheaths is simple and straightforward as well. I
am looking forward to seeing this product in action.”

Selectra incorporates a streamlined, fully integrated hub to minimize
handling complexity and maximize the working length of the sheath during
implant. Its hydrophilic inner coating reduces friction and facilitates
maneuverability. In addition, Selectra is fully slittable to reduce the
likelihood of moving the left ventricular lead as the sheath is removed.

The Selectra lead delivery system complements BIOTRONIK’s broad CRT
portfolio, which includes Corox BP leads and premium Lumax CRT-D
devices. In January 2011, BIOTRONIK launched the newest member of the
Corox BP lead family, the Corox OTW-L BP, which offers a third unique
design with excellent stability and handling characteristics.

About BIOTRONIK SE & Co. KGAs one of the world’s
leading manufacturers of cardiovascular medical devices, with several
million devices implanted, BIOTRONIK is represented in over 100
countries by its global workforce of over 5,600 employees. Known for
having its finger on the pulse of the medical community, BIOTRONIK
assesses the challenges physicians face, and provides the best solutions
for all phases of patient care, ranging from diagnosis to treatment to
patient management. Quality, innovation and reliability define BIOTRONIK
and its growing success, and deliver confidence and peace of mind to
physicians and their patients worldwide.